Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease

Apostolova, 2007, Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease, Arch. Neurol., 64, 1489, 10.1001/archneur.64.10.1489 Ashburner, 2007, A fast diffeomorphic image registration algorithm, NeuroImage, 38, 95, 10.1016/j.neuroimage.2007.07.007 Ashburner, 2012, Symmetric diffeomorphic modeling of longitudinal structural MRI, Front. Neurosci., 6, 197 Bates, 2015, Fitting linear mixed-effects models using lme4, J. Stat. Softw., 67, 10.18637/jss.v067.i01 Bechtel, 2010, Tapping linked to function and structure in premanifest and symptomatic Huntington disease, Neurology, 75, 2150, 10.1212/WNL.0b013e3182020123 R Core Team, 2016 Cox, 2015, Compensation or inhibitory failure? Testing hypotheses of age-related right frontal lobe involvement in verbal memory ability using structural and diffusion MRI, Cortex, 63, 4, 10.1016/j.cortex.2014.08.001 Feigin, 2007, Thalamic metabolism and symptom onset in preclinical Huntington's disease, Brain, 130, 2858, 10.1093/brain/awm217 Johnson, 2015, The impact of occipital lobe cortical thickness on cognitive task performance: an investigation in Huntington's disease, Neuropsychologia, 79, 138, 10.1016/j.neuropsychologia.2015.10.033 Klöppel, 2009, Functional compensation of motor function in pre-symptomatic Huntington's disease, Brain, 132, 1624, 10.1093/brain/awp081 Klöppel, 2015, Compensation in preclinical Huntington's disease: evidence from the Track-On HD Study, EBioMedicine, 2, 1420, 10.1016/j.ebiom.2015.08.002 Kurth, 2015, A 12-step user guide for analyzing voxel-wise gray matter asymmetries in statistical parametric mapping (SPM), Nat. Protoc., 10, 293, 10.1038/nprot.2015.014 Labuschagne, 2016, Visuospatial processing deficits linked to posterior brain regions in Premanifest and early stage Huntington's disease, J. Int. Neuropsychol. Soc., 22, 595, 10.1017/S1355617716000321 Lambrecq, 2013, Evolution of brain gray matter loss in Huntington's disease: a meta-analysis, Eur. J. Neurol., 20, 315, 10.1111/j.1468-1331.2012.03854.x McColgan, 2017, White matter predicts functional connectivity in premanifest Huntington's disease, Ann. Clin. Transl. Neurol., 4, 106, 10.1002/acn3.384 Minkova, 2017, Grey matter asymmetries in aging and neurodegeneration: a review and meta-analysis, Hum. Brain Mapp., 10.1002/hbm.23772 Mühlau, 2007, Striatal gray matter loss in Huntington's disease is leftward biased, Mov. Disord., 22, 1169, 10.1002/mds.21137 Nana, 2014, Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington's disease, J. Huntingtons. Dis., 3, 45, 10.3233/JHD-140092 Penney, 1997, CAG repeat number governs the development rate of pathology in Huntington's disease, Ann. Neurol., 41, 689, 10.1002/ana.410410521 Pievani, 2014, Brain connectivity in neurodegenerative diseases—from phenotype to proteinopathy, Nat. Rev. Neurol., 10, 620, 10.1038/nrneurol.2014.178 Reilmann, 2010, Grasping premanifest Huntington's disease - shaping new endpoints for new trials, Mov. Disord., 25, 2858, 10.1002/mds.23300 Reilmann, 2010, Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease, Mov. Disord., 25, 2195, 10.1002/mds.23243 Reilmann, 2015, A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease, Mov. Disord., 30, 427, 10.1002/mds.26174 Rosas, 2008, Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity, Brain, 131, 1057, 10.1093/brain/awn025 Ross, 2014, Huntington disease: natural history, biomarkers and prospects for therapeutics, Nat. Rev. Neurol., 10, 204, 10.1038/nrneurol.2014.24 Say, 2011, Visuomotor integration deficits precede clinical onset in Huntington's disease, Neuropsychologia, 49, 264, 10.1016/j.neuropsychologia.2010.11.016 Tabrizi, 2009, Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data, Lancet Neurol., 8, 791, 10.1016/S1474-4422(09)70170-X Tabrizi, 2011, Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis, Lancet Neurol., 10, 31, 10.1016/S1474-4422(10)70276-3 Tabrizi, 2012, Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data, Lancet Neurol., 11, 42, 10.1016/S1474-4422(11)70263-0 Tabrizi, 2013, Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data, Lancet Neurol., 12, 637, 10.1016/S1474-4422(13)70088-7 1993, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes, Cell, 72, 971, 10.1016/0092-8674(93)90585-E Thompson, 2001, Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas, Cereb. Cortex, 11, 1, 10.1093/cercor/11.1.1 Thompson, 2003, Dynamics of gray matter loss in Alzheimer's disease, J. Neurosci., 23, 994, 10.1523/JNEUROSCI.23-03-00994.2003 Toga, 2003, Mapping brain asymmetry, Nat. Rev. Neurosci., 4, 37, 10.1038/nrn1009 Wachinger, 2016, Whole-brain analysis reveals increased neuroanatomical asymmetries in dementia for hippocampus and amygdala, Brain, 10.1093/brain/aww243 Wolf, 2008, Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load, Eur. J. Neurol., 15, 1180, 10.1111/j.1468-1331.2008.02253.x Wolf, 2014, Visual system integrity and cognition in early Huntington's disease, Eur. J. Neurosci., 40, 2417, 10.1111/ejn.12575